FDA approves Opdivo and Cabometyx combo for advanced kidney cancer treatment

pharmanewsdaily- January 26, 2021 0

The U.S. Food and Drug Administration (FDA) has officially approved the combination of Bristol Myers Squibb's Opdivo (nivolumab) and Exelixis' Cabometyx (cabozantinib) for the first-line ... Read More

BRILINTA FDA approval: A major step in reducing stroke risks in acute ischemic stroke and high-risk TIA patients

pharmanewsdaily- November 8, 2020 0

AstraZeneca has secured U.S. Food and Drug Administration (FDA) approval for BRILINTA (ticagrelor), expanding its use to reduce the risk of stroke in patients suffering ... Read More

Masimo gets FDA clearance for Centroid patient monitoring sensor

pharmanewsdaily- June 28, 2020 0

Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company's wearable, wireless patient orientation, ... Read More

PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status

pharmanewsdaily- February 20, 2020 0

PADCEV, KEYTRUDA combination : Astellas Pharma and Seattle Genetics said that the combination of PADCEV (enfortumab vedotin-ejfv) and Merck's anti-PD-1 therapy KEYTRUDA (pembrolizumab) has been ... Read More

LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection

pharmanewsdaily- January 1, 2020 0

Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More

1215 / 15 Posts